Acquisition Synergy Leverage the 2022 acquisition of Aztec by Trinity Consultants to position cross-sell opportunities in life sciences manufacturing, combining Aztec’s automation and data analytics capabilities with Trinity’s broader process engineering and regulatory expertise.

Regulated Manufacturing Target biotech, pharmaceutical, and medical device firms that require validated facilities, commissioning, startup, and IQ/OQ/PQ services, highlighting Aztec’s experience in regulated environments to drive project wins.

Automation & Data Emphasize Aztec’s strengths in automation, SCADA, Syncade MES, and data analytics to prospects seeking improved process control, batch traceability, and operational efficiency in life sciences and utilities sectors.

Mid‑Market Focus Position as a specialized partner for mid-sized manufacturers (50–200 employees) in biotech, pharma, and chemical segments, offering cost-effective, on-time, within-budget project delivery with focused engineering and IT integration.

Integrated Services Promote end-to-end capabilities spanning engineering, process automation, project management, and IT services to differentiate from pure automation shops and appeal to clients needing seamless design-to-validation execution.